|
FRG1B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.719170E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.282670E-03 |
| Normal-vs-Stage2 |
1.898430E-01 |
| Normal-vs-Stage3 |
4.731400E-01 |
| Normal-vs-Stage4 |
3.638400E-02 |
| Stage1-vs-Stage2 |
9.356800E-01 |
| Stage1-vs-Stage3 |
3.168200E-01 |
| Stage1-vs-Stage4 |
5.593800E-01 |
| Stage2-vs-Stage3 |
5.798800E-01 |
| Stage2-vs-Stage4 |
6.191200E-01 |
| Stage3-vs-Stage4 |
3.279000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.499540E-02 |
| Normal-vs-AfricanAmerican |
9.400900E-04 |
| Normal-vs-Asian |
3.200100E-03 |
| Caucasian-vs-AfricanAmerican |
1.253750E-01 |
| Caucasian-vs-Asian |
3.401400E-01 |
| AfricanAmerican-vs-Asian |
6.498200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.045800E-04 |
| Normal-vs-Female |
1.581750E-01 |
| Male-vs-Female |
4.025200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.34940000000328E-05 |
| Normal-vs-Extreme_Weight |
2.143600E-03 |
| Normal-vs-Obese |
5.084000E-01 |
| Normal-vs-Extreme_Obese |
2.504500E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.654640E-01 |
| Normal_Weight-vs-Obese |
4.062300E-03 |
| Normal_Weight-vs-Extreme_Obese |
9.645400E-01 |
| Extreme_Weight-vs-Obese |
5.943700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.141000E-01 |
| Obese-vs-Extreme_Obese |
9.347800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.966000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.530620E-01 |
| Normal-vs-Age(61-80Yrs) |
1.433960E-04 |
| Normal-vs-Age(81-100Yrs) |
9.153100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.823000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.756400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.944380E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.482200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.886300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.074600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.697350E-03 |
| Normal-VS-Type2 PRCC |
4.597900E-03 |
| Normal-VS-KIRP CIMP |
3.760800E-01 |
| Normal-VS-Unclassified PRCC |
9.348600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.025200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.194600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.644170E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.721000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.546300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.072800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.3667000000005E-05 |
| Normal-vs-N1 |
9.544400E-01 |
| Normal-vs-N2 |
1.809280E-04 |
| N0-vs-N1 |
1.838290E-02 |
| N0-vs-N2 |
2.512200E-01 |
| N1-vs-N2 |
7.110100E-02 |
|
|
